Ethyl cyanoglyoxylate-2-oxime
Suppliers
Names
[ CAS No. ]:
3849-21-6
[ Name ]:
Ethyl cyanoglyoxylate-2-oxime
[Synonym ]:
OxiMa
Ethyl isonitrosocyanoacetate
EINECS 223-351-3
Ethyl cyanoximidoacetate
Ethyl Cyano(hydroxyimino)acetate
Acetic acid, 2-cyano-2-(hydroxyimino)-, ethyl ester, (2E)-
ETHYL OXIMINOCYANOACETATE
ETHYL CYANOGLYOXYLATE OXIME
ETHYL CYANOGLYOXALATE-2-OXIME
Ethyl Cyanoglyoxylate-2-Oxime
Cyano(hydroxyimino)acetic Acid Ethyl Ester
Ethyl (Hydroxyimino)cyanoacetate
Oxyma Pure
Ethyl (2E)-cyano(hydroxyimino)acetate
2-Ethyloximinocyanocaetate
Ethyl Cyanoglyoxalate Oxime
MFCD00002112
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
248.9±23.0 °C at 760 mmHg
[ Melting Point ]:
130-132 °C(lit.)
[ Molecular Formula ]:
C5H6N2O3
[ Molecular Weight ]:
142.11
[ Flash Point ]:
104.3±22.6 °C
[ Exact Mass ]:
142.037842
[ PSA ]:
82.68000
[ LogP ]:
0.35
[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C
[ Index of Refraction ]:
1.496
[ Storage condition ]:
2-8°C
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn:Harmful;
[ Risk Phrases ]:
R20/21/22
[ Safety Phrases ]:
S22-S24/25-S36/37
[ RIDADR ]:
3276
[ WGK Germany ]:
3
[ Packaging Group ]:
III
[ Hazard Class ]:
6.1
[ HS Code ]:
2928000090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2928000090
[ Summary ]:
2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%
Articles
Eur. J. Pharm. Biopharm. 88(2) , 351-60, (2014)
Several curcumin derivatives are now becoming increasingly of interest because of their bioactive attributes, especially their action as antioxidants and anti-carcinogenic activities. Tetrahydrocurcum...
COMU-Safer and More Efficient Peptide Coupling Reagent. Junkers M.COMU-Safer and More Efficient Peptide Coupling Reagent.
Aldrich Chemfiles 10(1) , (2010)
Proc. Natl. Acad. Sci. U. S. A. 108(17) , 6799-804, (2011)
Fragment-based drug discovery (FBDD) has proven to be an effective means of producing high-quality chemical ligands as starting points for drug-discovery pursuits. The increasing number of clinical ca...